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Abstract
Background: The human condition known as Premature Ovarian Failure (POF) is characterized by loss of ovarian function
before the age of 40. A majority of POF cases are sporadic, but 10–15% are familial, suggesting a genetic origin of the
disease. Although several causal mutations have been identified, the etiology of POF is still unknown for about 90% of the
patients.
Methodology/Principal Findings: We report a genome-wide linkage and homozygosity analysis in one large
consanguineous Middle-Eastern POF-affected family presenting an autosomal recessive pattern of inheritance. We
identified two regions with a LODmax of 3.26 on chromosome 7p21.1-15.3 and 7q21.3-22.2, which are supported as
candidate regions by homozygosity mapping. Sequencing of the coding exons and known regulatory sequences of three
candidate genes (DLX5, DLX6 and DSS1) included within the largest region did not reveal any causal mutations.
Conclusions/Significance: We detect two novel POF-associated loci on human chromosome 7, opening the way to the
identification of new genes involved in the control of ovarian development and function.
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Introduction
Premature ovarian failure (POF; MIM 311360 [OMIM]),
clinically characterized by the early loss of normal ovarian
function, is a cause of infertility in women under the age of 40
[1,2,3,4]. POF can result from different ovarian defects, including
early decrease in the primordial follicle pool, increased or
accelerated follicular atresia and follicle growth blockade. The
clinical characteristics of POF are a primary or secondary
amenorrhea associated with elevated levels of circulating gonad-
otropins LH and FSH [5].
Although POF may be due to metabolic, autoimmune,
infectious or iatrogenic causes, compelling evidence suggests that
certain forms of the disease have a genetic etiology. Many POF
cases are familial [6,7,8,9] and specific genetic alterations or
mutations have been associated with syndromic or non-syndromic
forms of the disease. The most frequent anomalies are X
chromosome alterations, including X chromosome monosomy
(Turner syndrome) [10], X deletions and translocations, mutations
of the BMP15 gene [11,12,13], and premutations of the FMR1
gene (Fragile X syndrome) [3]. POF-associated mutations were
also identified in autosomal genes, such as ATM [14,15], FSHR
[16], GDF9 [13,17], NOBOX [18,19], AIRE [20], StAR [21] and
FOXL2 [22,23,24,25].
Despite these progresses, the etiology of POF remains unknown
in about 90% of POF patients, suggesting that the causes of the
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33412disease are highly heterogeneous [5]. Therefore, a comprehensive
identification of POF-predisposing genes is necessary to acquire a
more accurate vision of the genetic causes of the disease.
Genome-wide linkage analysis has been successfully used to
identify causal mutations in human diseases, including POF, for
which such approach led to the identification of a 15.8 Mb region
on chromosome 5 [7] and a mutation in POF1B on the X
chromosome [6]. In order to identify novel POF-associated loci,
we analyzed a large, highly consanguineous, non-syndromic POF
family using a combination of genome-wide linkage and
homozygosity mapping.
Materials and Methods
Ethical Statement
The research protocol was approved by the Medical Center
Ethical Committee of the Hadassah University Hospital (Jerusa-
lem). Written informed consent was obtained from all individuals
included in the study.
Participants and Data Collection
A disease gene mapping was initiated in a large highly
consanguineous Middle Eastern family (MO1). The MO1
Palestinian family (pedigree in Figure 1), with 5 affected women,
was recruited through the Genetic Department of Hadassah
Hospital in Jerusalem. Medical reports were obtained and
completed when possible. Blood samples were collected for
hormonal, genomic and cytogenetic studies. Karyotypes and
genomic DNA isolation were performed by standard procedures.
The proband is the eldest of 6 sisters, 4 of them being affected
with POF with primary amenorrhea. Their mother and father are
first cousins, connected through at least 3 earlier consanguineous
marriages. The non-affected mother and the affected maternal
aunt were also born from a consanguineous marriage between first
cousins, born from consanguineous marriages as well. The
proband was diagnosed with POF at the age of 17 years because
of amenorrhea, small and undeveloped breasts and streak gonads
in ultrasound scan. The three other affected sisters were diagnosed
with POF on the basis of a similar phenotype at ages between 18
and 20. All affected sisters presented with a normal uterus, but
small ovaries with the appearance of ‘‘streak gonads’’ upon
echography. Their height was within the normal range. Karyo-
type, FMR1 premutation analysis and hormonal dosage were
performed at the time of diagnosis (Table 1). No increased
sedimentation rate or any other abnormal test for the presence of
auto antibodies could be found in any patient. At the age of 19, the
youngest POF patient suffered from a simultaneous bilateral
ovarian cancer. After surgery, histological analysis revealed a
gonadoblastoma on the right ovary, and a complex dysgermino-
ma/embryonic carcinoma/choriocarcinoma in the tumor of the
left ovary. In addition to these four cases, a maternal aunt
(individual 12, Figure 1) was diagnosed with POF and primary
amenorrhea (her DNA was not available for the genome-wide
linkage analysis). The non-affected sisters of the proband had
menarche at ages within the normal range, and conceived
naturally 2 and 3 children, respectively.
Microsatellites genotyping and SNP genotyping
Genotyping was performed on anonymous samples without
knowledge of any personal identifiers at the Genotyping platform
from the Institut de Ge ´nomique (Evry, France). After a genome-
wide linkage analysis with 457 microsatellite markers (average
autosomal marker spacing of 10 cM) that identified a significant
linkage on chromosome 7, we performed a high-resolution genome-
wide scan, using the Affymetrix GeneChipH Human Mapping
250 K Nsp Array (Affymetrix Inc., Santa Clara, CA). On this array,
bi-allelic markers are equally distributed across the genome with a
median physical distance between SNPs of 4.8 kb, an average
distance of 11.2 kb, and an average 0.30 of heterozygosity. The
Affymetrix genome-wide genotyping was performed according to
the standard manufacturer’s protocol (GeneChipH Mapping 250 K
Assay Manual Rev. 3/96-Well Plate Protocol), using 250 ng of
genomic DNA per sample. Washing and staining steps were
performed with Affymetrix GeneChipH Fluidics Station 450 and
scanning step with the Affymetrix GeneChipH Scanner 3000 7 G.
Raw data were obtained with Affymetrix GeneChipH Operating
Software (GCOS). Data were extracted with Affymetrix Gene-
ChipH Genotyping Analysis Software (GTYPE) using BRLMM
model as genotype calling method.
Linkage analysis and Homozygosity mapping
After classical filtering of SNP markers for genotyping quality,
mendelian errors and verification of Hardy-Weinberg equilibrium,
multipoint parametric linkage analysis was performed with Merlin
under the assumption of recessive inheritance, with a disease allele
frequency of 0.0001 and a penetrance of 0.99 [26]. The
haplotypes in the identified 7q21-22 region were reconstructed
with Merlin and presented graphically with HaploPainter v.1.043
[27]. The homozygous regions were confirmed and displayed
using the dedicated software KinSNP (http://bioinfo.bgu.ac.il/
bsu/software/KinSNP/) [28]. POF patients in the MO1 family
were searched for runs of shared homozygosity (ROSHs) with a
minimum length of 1 cM according to the deCode genetic map.
The degree of tolerance for genotyping errors within ROSHs was
adjusted such that heterozygous calls surrounded by 15 or more
shared homozygous SNPs were ignored.
Sequencing of candidate genes
Candidate genes were amplified by PCR from genomic DNA of
one affected POF patient and one non-affected sister (details of
primers and PCR conditions are provided in Document S1). PCR
products were sequenced by standard Sanger sequencing.
Results and Discussion
Linkage analysis in a highly consanguineous POF family
The highly consanguineous MO1 family (Figure 1) includes 5
POF patients in two generations (familial and clinical details in
Material and Methods and Table 1). Although it was not possible
to retrieve further familial information to assess earlier consan-
guinity loops, the high degree of consanguinity in this family
strongly suggested an autosomal recessive inheritance of the
disease allele from a common ancestor. A first genome-wide
linkage analysis with 457 microsatellite markers identified a
10.5 Mb-long region within 7q21-22 (maximum LOD-score
(LODmax) of 3.8). A second whole-genome scan with a 250 K
SNP array identified four chromosomal regions with significant
linkage under a recessive model (LODmax=3.26, Figure 2 and
Table 2). It confirmed the significant linkage for a 9.96 Mb region
on 7q21.3-22.2. It identified also an additional 2.56 Mb-long
linkage region in 7p21.1, and two narrow segments, each spanning
less than 0.2 Mb, within a short region of 6.6 Mb in 13q14. These
regions had not been detected by the first genome-wide scan, since
they were entirely framed by the analyzed microsatellites.
Both regions on chromosome 7 are supported as candidate
regions for the disease gene because they are detected as large runs
of shared homozygosity by KinSNP (data not shown), and by a
correct transmission of haplotypes, as reconstructed by Merlin.
Two Novel Loci for Non-Syndromic Familial POF
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Individual Type of amenorrhea FSH (mIU/ml) Estradiol (pg/ml) LH (mUI/ml) Karyotype FMR1 premutation
MO1–3 primary 63.1 20.2 19.9 46,XX No
MO1–7 primary 51.4 12.1 21.1 46,XX No
MO1–8 primary 45.7 12.5 18.0 46,XX No
MO1–9 primary 55.3 22.0 18.0 46,XX No
Reference values 3–21 30–190 1.0–14.7
doi:10.1371/journal.pone.0033412.t001
Figure 1. Pedigree of the consanguineous MO1 family, with haplotype reconstruction of the 7q21-22 region. Squares indicate males
and circles indicate females. Black symbols indicate women affected with Premature Ovarian Failure. Year of birth, when known, is indicated below
the number of the individual. Double connecting lines indicate consanguineous marriages, all known to be between first cousins even when the
precise consanguinity loop could not be established. Asterisks mark the individuals included in the microsatellite and/or the SNP whole-genome
genotyping studies. The haplotypes for the large 7q21-22 region were reconstructed with Merlin [26] for the individuals genotyped on the SNP array,
and visualized with HaploPainter. For the sake of simplicity, the number of depicted SNPs was reduced, to 3 SNPs at the border of the shared
homozygous block (2 SNPs out and 1 SNP in) and to approximately 1 informative SNP/cM inside the block. A red bar represents the ancestral disease
haplotype transmitted both by the mother 1 and the father 2, and the green and blue bars represent the wild-type haplotypes. Recombination
events in individuals 3 and 8 delimit the region of interest between the external markers rs11768589 and rs2727744 (horizontal lines).
doi:10.1371/journal.pone.0033412.g001
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the homozygous state because of the inheritance from a common
ancestor through the paternal and maternal branches. Their non-
affected sisters were either heterozygous (individual 6) or non-
carrier (individual 10) for the disease haplotype (Figure 1). In
addition, as the haplotypes confirmed that the affected sisters were
not hemizygous for these regions, the mutation is not a large-scale
deletion. Five larger ROSHs are detected by KinSNP, but in all
these, the non-affected mothers and all the daughters shared the
same haplotype at the homozygous state, which is incompatible
with the transmission of the disease in the family. Therefore, the
candidate region on the 7q21.3-22.2 is the largest homozygous
stretch compatible with linkage.
The two peaks on chromosome 13 are not detected as ROSHs
by KinSNP, due to the small size of the homozygous stretches.
However, a visual inspection of the haplotypes in the KinSNP
output confirmed that these peaks indeed contain a range of SNPs
that are homozygous by descent in the four affected sisters, and
heterozygous in the non-affected sisters and the non-affected
mother (data not shown). Additional linkage analysis along 0.2,
0.4, 0.6, 0.8 and 1 cM grids on chromosome 13 showed that the
positive peaks disappeared only with the setting of 1 cM. Thus,
those peaks probably do not result from linkage disequilibrium and
are likely to reflect identity-by-state homozygosity.
In addition, the SNP-based linkage analysis identified a near-
significant region of 0.19 Mb on Xp22.33, that spans the
boundary between the pseudo-autosomal region and the X
specific region (LOD=2.94, figure 2). This peak is detected as a
ROSH by KinSNP. However, the analysis of the haplotypes
revealed that the non-affected mother, the healthy sisters, as well
Figure 2. Whole genome linkage analysis for the MO1 family. The multipoint parametric LOD-score is plotted against the physical location of
markers along the genome. The chromosome number is indicated in the upper part of the graph. Genotype analysis was performed on the
Affymetrix GeneChipH Human Mapping 250 K Nsp Array (Affymetrix Inc., Santa Clara, CA). A significant LOD-score was obtained for two regions on
chromosome 7. The apparent single peak on chromosome 13 encompasses two distinct very small peaks.
doi:10.1371/journal.pone.0033412.g002
Table 2. Characteristics of significant LOD-score loci identified by genome-wide linkage in the MO1 family.
Chrom 7 7 13 13
Cytoband 7p21.1 7p15.3 7q21.3 7q22.2 13q14.12 13q14.3
LOD max 3.257 3.257 3.257 3.257
# of SNPs 297 643 25 27
Flanking SNP rs13222101 rs7806550 rs11768589 rs17152355 rs4245330 rs2248414 rs536338 rs797493
Position (cM) 31.654 34.696 106.189 115.436 47.21 47.495 53.166 53.377
Size (cM) 3.042 9.247 0.285 0.211
Position (bp, in
GRCh37)
17723272 20278642 95615196 105575202 44661321 44798197 51103461 51261023
Size (Mb) 2.56 9.96 0.14 0.16
Homozyg. YES YES NO NO
# of genes 11+5 pseudogenes 166+39 pseudogenes 1 hypothetical 1 (2 terminal exons)
Candidate Genes SHFM1, DLX5, DLX6
The flanking SNPs are the first ones outside the LODmax peak, defined as having a LOD-score,LODmax-2 or LOD-score,LODmax-1. The Homozyg. line indicates whether
the linkage peak was detected as a run of shared homozygosity by the KinSNP analysis.
doi:10.1371/journal.pone.0033412.t002
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homozygous state for 15 of the 20 SNPs within the peak (data not
shown). Therefore, it is highly unlikely that this locus contains the
mutation responsible for the POF phenotype in this family.
Sequencing of POF candidate genes in the MO1 family
In total, the two loci on chromosome 7 span 12.29 cM and
12.52 Mb, and contain 177 genes (details of positions, sizes and
genes content for all peaks with a LOD-score above 3 are
presented in Table 2, and a list of all the genes located in these
regions in Table S1).
We cannot exclude the smaller loci on chromosome 13 as
possibly containing the mutation involved in this familial POF,
however they do not contain any evident functional candidate
gene, if any gene at all. The first locus on chromosome 13 could
possibly contain one gene (C13orf44), but the corresponding
RefSeq sequences were permanently suppressed from the Gene
database because there is currently insufficient support for the
transcript and the protein (GeneID 79024). The second locus on
chromosome 13 contains only the 2 terminal exons of two
transcripts of the DLEU1 gene, a long non-coding RNA gene with
multiple splicing variants implicated as a tumor suppressor in B-
cell chronic lymphocytic leukemia.
Similarly, the region on 7p21.1 does not contain any obvious
functional candidate genes. TWIST1 was formerly known as the
BPES3 locus, because eyelid features of some patients with
Saethre-Chotzen syndrome, due to mutations in TWIST1, were
similar to those presented by patients with BPES. Nevertheless,
this specific phenotype observed in those patients affected with
Saethre-Chotzen syndrome was later recognized to be due to
phenotypic variability. In addition, patients with Saethre-Chotzen
syndrome do not present any ovarian defects. Therefore TWIST1
cannot be considered as a POF candidate gene.
On the contrary, the region on 7q21.3-22.3 includes at least
three POF functional candidate genes. DLX5 and DLX6 code for
two closely linked homeobox transcription factors, involved in the
control of steroidogenesis [29]. The allelic reduction of Dlx5 and
Dlx6 in the mouse is associated with a POF-like phenotype, with
an early reduction of fertility and a rapid and premature follicular
depletion. This study also provided evidence supporting a
reciprocal regulation between Dlx5, Dlx6 and Foxl2, a transcription
factor essential for ovarian development and function, also
implicated in POF [30,31,32]. Another potential candidate gene
is SHFM1, located in close proximity of the DLX5/DLX6 locus. Its
nematode ortholog, dss-1, is functionally conserved during
evolution and was shown to be required for oogenesis and normal
female fertility in C. elegans (with no impact on gonad development
or on male fertility) [33]. The murine Dss1 is expressed in the early
genital tubercle during fetal development, and in the early genital
bud of the newborn mice [34]. Although these three genes are
implicated in the etiology of the Split Hand/Split Foot
Malformation Type I syndrome (SHFM1, MIM%183600) [35],
their possible function in the ovary prompted us to sequence them
in the MO1 family. Sequencing of the coding, promoter and
known enhancers regions of DLX5 and DLX6 did not show any
DNA variants segregating with the disease. Likewise, we did not
find any variants in the promoter and coding sequence of SHFM1.
Conclusions
We have indentified two novel POF-associated loci on
chromosome 7, that do not coincide with the regions identified
by genome-wide linkage in the two previous studies of familial
POF cases: the POF1B gene on the X chromosome, and a
15.8 Mb region in 5q14.1-q15 [6,7]. In addition, these regions on
chromosome 7 are not included and do not contain the CNVs that
were detected as statistically different from controls in POF
patients by Aboura and colleagues [36]. The identification of two
other putative loci in our study highlights the important genetic
heterogeneity of this disease.
The fact that the severe ovarian cancer affecting the youngest
POF patient (individual 9) was bilateral and simultaneous strongly
suggests a genetic origin. However, the association between POF
and ovarian cancer is highly unusual and, to our knowledge, was
never described before. Besides, a direct relation between POF
and ovarian cancer is doubtful since only one POF-affected sister
developed a cancer at a young age. Therefore it is more likely that
the co-occurrence of these diseases in this patient could be related
to the high familial consanguinity.
We could not find any sequence variant segregating with the
disease in the coding and known regulatory sequences of DLX5/6
and the coding sequence of SHFM1. Although we cannot exclude
the existence of still unknown regulatory features, possibly
affecting both SHFM1 and DLX5/DLX6, which could harbor
the causal mutation for POF in our family, the most likely
hypothesis is that the mutation is present in the coding sequence of
another gene located in the 7p or the 7q regions.
Among those genes, other possible candidates include
SMURF1,t h eCYP3 gene family and VGF. SMURF1 encodes
an E3 ubiquitin ligase specific of regulatory SMAD proteins, that
was shown in rat and human granulosa cell lines to ubiquitinylate
R-Smad 1 and 5, two of the regulatory Smads activated by
oocyte-secreted BMP15, a known POF gene [37]. The CYP3
gene cluster in 7q includes four genes, CYP3A43, CYP3A4,
CYP3A7 and CYP3A5, encoding cytochrome P450 enzymes,
known to be implicated in drug metabolism and synthesis of
cholesterol and steroids. Although some of the CYP3A genes
appear to have a restricted expression in the liver and to be
mainly responsible for drug detoxification, we cannot exclude a
role in steroid synthesis in the ovary [38]. VGF encodes a 68-kDa
precursor of multiple bioactive peptides with diverse neuroen-
docrine functions, expressed abundantly in the brain, and in
peripheral endocrine tissues including the pituitary gland. In
addition to a role in the regulation of energy homeostasis, VGF
could also regulate reproduction, since homozygous Vgf-null
mice are infertile, presenting a delayed sexual maturation,
incomplete mammary development and ovaries with only
primary and atretic follicles, apparently due to an abnormal
pitituary gonadotropin content [39].
As the two loci identified on chromosome 7 contain too many
genes for a direct sequencing approach in search of the causal
mutation, we plan to proceed to an exome-sequencing in the MO1
family. Hopefully, this study will enable us to identify the mutation
implicated in Premature Ovarian Failure in this family and might
lead to the identification of one or several genes involved in the
control of ovarian function and development.
Supporting Information
Document S1 Primers and conditions of PCR used for
sequencing SHFM1, DLX5 and DLX6.
(DOC)
Table S1 List of genes present in the loci identified on
chromosomes 7 and 13 by genome-wide linkage in the
MO1 POF family. The lists were established using the NCBI
Genome Viewer, using the rs number of the border SNPs, as given
in Table 1. Pseudogenes are written in grey.
(XLS)
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